SOLARA ACTIVE PHARMA SCIENCES LIMITED — Call Transcript 2022

Aug 4, 2022

Communication Address: Solara Active Pharma Sciences Limited 2nd Floor, Admin Block

27, Vandaloor Kelambakkam Road, Chennai – 600 127, India Tel : +91 44 43446700 Fax : +91 44 47406190 E-mail : investors@solara.co.in www.solara.co.in

Keelakottaiyur Village, Melakottaiyur (Post)

August 4, 2022

The BSE Limited Phiroze Jeejeebhoy Towers Dalal Street, Mumbai – 400 001 Scrip Code: 541540

The National Stock Exchange of India Limited Exchange Plaza, Bandra-Kurla Complex Bandra (E), Mumbai – 400 051

Scrip Code: SOLARA

Dear Sir / Madam,

Subject: Audio recordings of Q1 of FY23 earnings/quarterly call

Pursuant to Regulation 30 and 46 read with clause 15 of Para A of Part A of Schedule lll of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby confirm that we have uploaded audio recording of the Q1 of FY23 Earnings Call held on August 4, 2022, on our Company website under the heading Investor relations/Stock Exchange Communication/ Investor update.

Link for audio recording of Conference call is given below:

• https://solara.co.in/wp content/uploads/2022/08/SVS0320220804142472.mp3

This is for your information and records.

Thanking you,

Yours faithfully,

For Solara Active Pharma Sciences Limited

==> picture [146 x 39] intentionally omitted <==

S. Murali Krishna Company Secretary

Solara Active Pharma Sciences Limited - CIN : L24230MH2017PLC291636

REGD. OFF: 201, Devavrata, Sector 17, Vashi Navi Mumbai - 400703. India/ Tel: 91-22-2789 2924 / 2789 3199 / Fax: 91-22-2789 2942